#AI-Powered Chatbots to Drive Dramatic Cost Savings in Healthcare, Saving $3.6 Billion by 2022
Hampshire, UK - October 11, 2017 (Investorideas.com Newswire) A new report from Juniper Research has found that annual cost savings derived from the adoption of chatbots in healthcare will reach $3.6 billion globally by 2022, up from an estimated $2.8 million in 2017. This growth will average 320% per annum, as AI (artificial intelligence) powered chatbots will drive improved customer experiences for patients.
Using sophisticated chatbot systems, patients will be able to access care more quickly and easily, improving access to care and reducing pressure on overworked healthcare systems by ensuring more efficient interactions.
Read more in Juniper's complimentary whitepaper, These AI Startups are Disrupting Healthcare in a Big Way.
China to Lead the Way in Chatbot Deployment
The new research, Digital Health: Vendor Analysis, Emerging Technologies & Market Forecasts 2017-2022, found that despite trials by, for example, the UK's National Health Service, chatbot deployment will be dominated by Far East & China over the next five years. Over half of the annual savings realised by chatbots will be attributable to this region in 2022. Owing to the varied quality of care in countries such as China, chatbots will be useful for directing patients to appropriate services, which in turn will drive adoption.
The research predicted that chatbots, when used to triage patients, would have a dramatic impact on healthcare efficiency. Juniper urged service providers to focus on overcoming the current poor level of interoperability of many healthcare IT systems in order to enable chatbots to unlock the full benefits possible. Additionally, it cited data security as critical towards maintaining patient trust.
Mature Healthcare Markets Slow to Adapt
Additionally, the research found that chatbots face substantial challenges in developed healthcare systems, such as those in the US and UK. Systems at a mature stage of development are generally more conservative in introducing new technology than others, often resulting in inefficient care.
Juniper believes that this conservatism will slow chatbot adoption relative to emerging markets such as China and India, where small-scale deployments are already occurring.
Juniper Research provides research and analytical services to the global hi-tech communications sector, providing consultancy, analyst reports and industry commentary.
TechSectorStocks.com - investing ideas in tech stocks- mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)
Like Tech Stocks? View our Tech Stocks Directory
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.